Response to crizotinib in a non-small-cell lung cancer patient harboring an EML4-ALK fusion with an atypical LTBP1 insertion

Response to crizotinib in a non-small-cell lung cancer patient harboring an EML4-ALK fusion with an atypical LTBP1 insertion

Cristina Aguado,1,* Maria-de-los-Llanos Gil,2,* Zaira Yeste,1 Ana Giménez-Capitán,1 Cristina Teixidó,1 Niki Karachaliou,2 Santiago Viteri,2 Rafael Rosell,1,2 Miguel A Molina-Vila1 1Laboratory of Oncology, Pangaea Oncology, 2Dr Rosell Oncology Institute, Quir&oac...

Full description

Bibliographic Details
Main Authors: Aguado C, Gil MDLL, Yeste Z, Giménez-Capitán A, Teixidó C, Karachaliou N, Viteri S, Rosell R, Molina-Vila MA
Format: Article
Language:English
Published: Dove Medical Press 2018-03-01
Series:OncoTargets and Therapy
Subjects:
Lung cancer
NSCLC
EML4-ALK
LTBP1
crizotinib
targeted therapy
Online Access:https://www.dovepress.com/response-to-crizotinib-in-a-non-small-cell-lung-cancer-patient-harbori-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/response-to-crizotinib-in-a-non-small-cell-lung-cancer-patient-harbori-peer-reviewed-article-OTT

Similar Items